Louisbourg Investments Inc. Cuts Stock Holdings in Nutrien Ltd. (NYSE:NTR)

Louisbourg Investments Inc. lessened its holdings in Nutrien Ltd. (NYSE:NTR) by 1.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 88,643 shares of the company’s stock after selling 1,731 shares during the quarter. Louisbourg Investments Inc.’s holdings in Nutrien were worth $3,964,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in the business. Silchester International Investors LLP lifted its holdings in shares of Nutrien by 164.4% in the 3rd quarter. Silchester International Investors LLP now owns 10,683,242 shares of the company’s stock valued at $513,437,000 after buying an additional 6,642,075 shares during the period. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in Nutrien in the third quarter valued at $150,181,000. ARGA Investment Management LP boosted its position in shares of Nutrien by 25.7% during the 4th quarter. ARGA Investment Management LP now owns 6,043,590 shares of the company’s stock worth $270,396,000 after purchasing an additional 1,236,671 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd grew its stake in shares of Nutrien by 78.8% during the 3rd quarter. Clal Insurance Enterprises Holdings Ltd now owns 2,495,282 shares of the company’s stock worth $121,271,000 after purchasing an additional 1,100,000 shares during the period. Finally, Toronto Dominion Bank increased its holdings in shares of Nutrien by 11.9% in the 3rd quarter. Toronto Dominion Bank now owns 4,220,354 shares of the company’s stock valued at $202,830,000 after purchasing an additional 447,413 shares in the last quarter. Hedge funds and other institutional investors own 63.10% of the company’s stock.

Nutrien Price Performance

NTR stock opened at $51.82 on Wednesday. The stock has a market capitalization of $25.45 billion, a price-to-earnings ratio of 34.78, a price-to-earnings-growth ratio of 1.13 and a beta of 0.81. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. Nutrien Ltd. has a 52-week low of $43.69 and a 52-week high of $60.87. The stock’s fifty day simple moving average is $48.87 and its 200-day simple moving average is $48.10.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the stock. Scotiabank boosted their price objective on shares of Nutrien from $59.00 to $60.00 and gave the stock a “sector outperform” rating in a report on Monday. Wells Fargo & Company lifted their price objective on Nutrien from $52.00 to $53.00 and gave the stock an “equal weight” rating in a report on Tuesday, January 28th. UBS Group upped their target price on Nutrien from $51.00 to $53.00 and gave the company a “neutral” rating in a report on Tuesday, January 28th. JPMorgan Chase & Co. upgraded Nutrien from an “underweight” rating to a “neutral” rating and raised their price target for the company from $40.00 to $50.00 in a research report on Monday, January 13th. Finally, Barclays reiterated an “equal weight” rating and issued a $56.00 price objective (up from $55.00) on shares of Nutrien in a research report on Tuesday, January 21st. One research analyst has rated the stock with a sell rating, six have given a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat, Nutrien presently has an average rating of “Moderate Buy” and a consensus target price of $59.00.

Nutrien Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.